IL6 and neoplasm: Intratumoural Escherichia-Shigella- and Enterobacteriaceae-derived LPS promoted NSCLC progression via the TLR4-mTOR-NF-κB-IL-6 axis, whereas the addition of the mTOR inhibitor rapamycin significantly suppressed LPS-induced tumor proliferation.